Does prenatal exposure to antidepressants cause autism? - literature review
DOI:
https://doi.org/10.12775/JEHS.2024.57.003Keywords
autism spectrum disorder (ASD), major depressive disorder (MDD), SSRI, ssri prenatal exposureAbstract
Autism spectrum disorder is an increasingly diagnosed disorder among children, yet its pathogenesis is still unknown. Possible causes are sought in genetic mutations, cellular processes occurring in the nervous system during development and external factors affecting the fetus during the prenatal period. In recent years, there have been an increasing number of reports linking the occurrence of the spectrum to antidepressant medications, especially from the SSRI group, taken by pregnant women for depressive disorders, which occur in up to a dozen percent of women in this group. The involvement of serotonin in the development of the nervous system during the fetal period is taken as the reason for this phenomenon. To date, no clear consensus has been reached on this issue, and many distractors in the research are highlighted, such as the effect of maternal depression on fetal development, among others. There is no doubt that further research is needed to better assess the risk of ASD associated with SSRI use and dosage during pregnancy
References
Gyawali S, Patra BN. Autism spectrum disorder: Trends in research exploring etiopathogenesis. Psychiatry Clin Neurosci. 2019;73(8):466-475. doi:10.1111/pcn.12860
Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism spectrum disorder. Lancet. 2018;392(10146):508-520. doi:10.1016/S0140-6736(18)31129-2
Hirota T, King BH. Autism Spectrum Disorder: A Review. JAMA. 2023;329(2):157-168. doi:10.1001/jama.2022.23661
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5), 5th edn Washington, DC: American Psychiatric Association Publishing, 2013.
Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med. 1995;25(1):63-77. doi:10.1017/s0033291700028099
Bristol MM, Cohen DJ, Costello EJ, et al. State of the science in autism: report to the National Institutes Health. J Autism Dev Disord. 1996;26(2):121-154. doi:10.1007/BF02172002
Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism spectrum disorder. Lancet. 2018;392(10146):508-520. doi:10.1016/S0140-6736(18)31129-2
Sandin S, Lichtenstein P, Kuja-Halkola R, Larsson H, Hultman CM, Reichenberg A. The familial risk of autism. JAMA. 2014;311(17):1770-1777. doi:10.1001/jama.2014.4144
Morales DR, Slattery J, Evans S, Kurz X. Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations. BMC Med. 2018;16(1):6. Published 2018 Jan 15. doi:10.1186/s12916-017-0993-3
Bhat RS, Alonazi M, Al-Daihan S, El-Ansary A. Prenatal SSRI Exposure Increases the Risk of Autism in Rodents via Aggravated Oxidative Stress and Neurochemical Changes in the Brain. Metabolites. 2023;13(2):310. Published 2023 Feb 20. doi:10.3390/metabo13020310
Gyawali S, Patra BN. Autism spectrum disorder: Trends in research exploring etiopathogenesis. Psychiatry Clin Neurosci. 2019;73(8):466-475. doi:10.1111/pcn.12860
Lyall K, Croen L, Daniels J, et al. The Changing Epidemiology of Autism Spectrum Disorders. Annu Rev Public Health. 2017;38:81-102. doi:10.1146/annurev-publhealth-031816-044318
Dimidjian S, Goodman S. Nonpharmacologic intervention and prevention strategies for depression during pregnancy and the postpartum. Clin Obstet Gynecol. 2009;52(3):498-515. doi:10.1097/GRF.0b013e3181b52da6
Bałkowiec-Iskra E, Mirowska-Guzel DM, Wielgoś M. Effect of antidepressants use in pregnancy on foetus development and adverse effects in newborns. Ginekol Pol. 2017;88(1):36-42. doi:10.5603/GP.a2017.0007
Tran, H., & Robb, A. S. (2015). SSRI use during pregnancy. Seminars in Perinatology, 39(7), 545–547.doi:10.1053/j.semperi.2015.08.010
Kim DR, O'Reardon JP, Epperson CN. Guidelines for the management of depression during pregnancy. Curr Psychiatry Rep. 2010;12(4):279-281. doi:10.1007/s11920-010-0114-x
Bourke CH, Stowe ZN, Owens MJ. Prenatal antidepressant exposure: clinical and preclinical findings. Pharmacol Rev. 2014;66(2):435-465. Published 2014 Feb 24. doi:10.1124/pr.111.005207
Yonkers KA, Blackwell KA, Glover J, Forray A. Antidepressant use in pregnant and postpartum women. Annu Rev Clin Psychol. 2014;10:369-392. doi:10.1146/annurev-clinpsy-032813-153626
Mezzacappa, A., Lasica, P.-A., Gianfagna, F., Cazas, O., Hardy, P., Falissard, B., … Gressier, F. (2017). Risk for Autism Spectrum Disorders According to Period of Prenatal Antidepressant Exposure. JAMA Pediatrics, 171(6),555. doi:10.1001/jamapediatrics.2017.0124
Kristensen JH, Ilett KF, Hackett LP, Yapp P, Paech M, Begg EJ. Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br J Clin Pharmacol. 1999;48(4):521-527. doi:10.1046/j.1365-2125.1999.00040.x
Källén, B. (2004). Neonate Characteristics After Maternal Use of Antidepressants in Late Pregnancy. Archives of Pediatrics & Adolescent Medicine, 158(4), 312. doi:10.1001/archpedi.158.4.312
Lattimore, K. A., Donn, S. M., Kaciroti, N., Kemper, A. R., Neal, C. R., & Vazquez, D. M. (2005). Selective Serotonin Reuptake Inhibitor (SSRI) Use during Pregnancy and Effects on the Fetus and Newborn: A Meta-Analysis. Journal of Perinatology, 25(9), 595–604. doi:10.1038/sj.jp.7211352
Huang H, Coleman S, Bridge JA, Yonkers K, Katon W. A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight. Gen Hosp Psychiatry. 2014;36(1):13-18. doi:10.1016/j.genhosppsych.2013.08.002
Oberlander, T. F., Warburton, W., Misri, S., Aghajanian, J., & Hertzman, C. (2008). Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: Population-based study. British Journal of Psychiatry, 192(05), 338–343. doi:10.1192/bjp.bp.107.037101
Mathew S, Bichenapally S, Khachatryan V, et al. Role of Serotoninergic Antidepressants in the Development of Autism Spectrum Disorders: A Systematic Review. Cureus. 2022;14(8):e28505. Published 2022 Aug 28. doi:10.7759/cureus.28505
Trowbridge S, Narboux-Nême N, Gaspar P. Genetic models of serotonin (5-HT) depletion: what do they tell us about the developmental role of 5-HT?. Anat Rec (Hoboken). 2011;294(10):1615-1623. doi:10.1002/ar.21248
Mulder, E. J., Anderson, G. M., Kema, I. P., de Bildt, A., van Lang, N. D., den Boer, J. A., & Minderaa, R. B. (2004). Platelet Serotonin Levels in Pervasive Developmental Disorders and Mental Retardation: Diagnostic Group Differences, Within-Group Distribution, and Behavioral Correlates. Journal of the American Academy of Child & Adolescent Psychiatry, 43(4), 491–499. doi:10.1097/00004583-200404000-00016
Muller, C. L., Anacker, A. M. J., & Veenstra-VanderWeele, J. (2016). The serotonin system in autism spectrum disorder: From biomarker to animal models. Neuroscience, 321, 24–41. doi:10.1016/j.neuroscience.2015.1
Croen LA, Grether JK, Yoshida CK, Odouli R, Hendrick V. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry. 2011;68(11):1104-1112. doi:10.1001/archgenpsychiatry.2011.73
Rai D, Lee BK, Dalman C, Golding J, Lewis G, Magnusson C. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ. 2013;346:f2059. Published 2013 Apr 19. doi:10.1136/bmj.f2059
Gidaya NB, Lee BK, Burstyn I, Yudell M, Mortensen EL, Newschaffer CJ. In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder. J Autism Dev Disord. 2014;44(10):2558-2567. doi:10.1007/s10803-014-2128-4
Hviid A, Melbye M, Pasternak B. Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. N Engl J Med. 2013;369(25):2406-2415. doi:10.1056/NEJMoa1301449
Sørensen MJ, Grønborg TK, Christensen J, Parner ET, Vestergaard M, Schendel D, Pedersen LH. Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol. 2013 Nov 15;5:449-59. doi: 10.2147/CLEP.S53009. PMID: 24255601; PMCID: PMC3832387.
Boukhris T, Sheehy O, Mottron L, Bérard A. Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children. JAMA Pediatr. 2016;170(2):117-124. doi:10.1001/jamapediatrics.2015.3356
Kapra O, Rotem R, Gross R. The Association Between Prenatal Exposure to Antidepressants and Autism: Some Research and Public Health Aspects. Front Psychiatry. 2020;11:555740. Published 2020 Nov 23. doi:10.3389/fpsyt.2020.555740
Andalib S, Emamhadi MR, Yousefzadeh-Chabok S, et al. Maternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review. Eur Psychiatry. 2017;45:161-166. doi:10.1016/j.eurpsy.2017.06.001
Kaplan YC, Keskin-Arslan E, Acar S, Sozmen K. Maternal SSRI discontinuation, use, psychiatric disorder and the risk of autism in children: a meta-analysis of cohort studies. Br J Clin Pharmacol. 2017;83(12):2798-2806. doi:10.1111/bcp.13382
Leshem R, Bar-Oz B, Diav-Citrin O, et al. Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: A True Effect or a Bias? A Systematic Review & Meta-Analysis. Curr Neuropharmacol. 2021;19(6):896-906. doi:10.2174/1570159X19666210303121059
Bai D, Yip BHK, Windham GC, et al. Association of Genetic and Environmental Factors With Autism in a 5-Country Cohort. JAMA Psychiatry. 2019;76(10):1035-1043. doi:10.1001/jamapsychiatry.2019.1411
Yang F, Chen J, Miao MH, et al. Risk of autism spectrum disorder in offspring following paternal use of selective serotonin reuptake inhibitors before conception: a population-based cohort study. BMJ Open. 2017;7(12):e016368. Published 2017 Dec 22. doi:10.1136/bmjopen-2017-016368
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Zuzanna Marczyńska, Patrycja Grabowska, Natalia Olesińska, Patrycja Bolla, Hanna Senat, Aleksandra Senat, Aleksandra Madej
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 365
Number of citations: 0